Poloxamers are vital nonionic surfactants used in pharmaceutical formulations, where their composition directly impacts performance and functionality. Regulatory compliance, as defined in the USP-NF and Ph. Eur. monographs, requires Nuclear Magnetic Resonance (NMR) analysis to ensure product consistency and quality.
Image Credit: Bruker BioSpin Division
The Bruker Fourier 80 benchtop NMR spectrometer offers an ideal platform for this type of testing. Compact and cryogen-free, it fulfills all technical requirements of the monographs and is specifically designed to meet the practical needs of Quality Control laboratories.
Bruker’s GxP kits, built on years of industry experience, further support full regulatory compliance without compromising on usability or automation capabilities.
Download the full whitepaper here.
About Bruker BioSpin Division
The Bruker BioSpin Division designs, manufactures, and distributes advanced scientific instruments based on magnetic resonance, preclinical imaging technologies, and biosensor technologies. These include our industry-leading NMR and EPR spectrometers, imaging systems utilizing MRI, PET, SPECT, CT, Optical and MPI modalities, as well as molecular interaction technologies like SPR, switchSENSE® and single-cell Interaction Cytometry (scIC). The Division also offers integrated software solutions and automation tools to support digital transformation across research and quality control environments.
Our customers in academic, government, industrial, and pharmaceutical sectors rely on these technologies to gain detailed insights into molecular structure, dynamics, and interactions. Our solutions play a key role in structural biology, drug discovery, disease research, metabolomics, and advanced materials analysis. Recent investments in lab automation, optical imaging, and contract research services further strengthen our ability to support evolving customer needs and enable scientific innovation.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.net, which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.